 fludarabin new agent mark cytoreduct activ untreat chronic lymphocyt leukemia thirty-thre patient chronic lymphocyt leukemia cll advanc rai stage iii-iv progress rai stage diseas fludarabin singl agent eleven patient complet remiss CR clinic CR residu nodul evid diseas nodular partial remiss PR patient PR total respons rate respons rapid cours treatment major morbid infect febril cours minor infect transient fever undocu caus fludarabin cytoreduct singl agent cll